BSECompany UpdateAuditor Change25 Sept 2026
MOLBIO DIAGNOSTICS LIMITED
MOLBIO DIAGNOSTICS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Molbio Diagnostics has informed BSE about the re-appointment of Cost Auditors - XBRL.
BSECompany Update25 Sept 2026
MOLBIO DIAGNOSTICS LIMITED
MOLBIO DIAGNOSTICS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Molbio Diagnostics has informed BSE about the re-appointment of Cost Auditors - XBRL.
BSECompany UpdateResults2 Sept 2026
Molbio Diagnostics Ltd
Intimation of Earnings Conference Call under Regulation 30 and all other applicable regulations, if any, of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) ....
Molbio Diagnostics Ltd has scheduled an Earnings Conference Call on September 8, 2026, to discuss its financial performance for the quarter ended June 30, 2026.
BSEBoard MeetingResults1 Sept 2026
Molbio Diagnostics Ltd
Molbio Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 ,inter alia, to consider and approve To consider and approve ....
Molbio Diagnostics Ltd has informed BSE that a meeting of the Board of Directors is scheduled on 05/09/2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2026.
BSEOthersMgmt Change27 Aug 2026
Molbio Diagnostics Ltd
Outcome of Board Meeting held on August 27, 2026, as per Reg 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations').
The Board of Directors of Molbio Diagnostics Ltd appointed Mr. Darshan Raghunath Karekar as the Compliance Officer under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
BSEInsider Trading / SASTRegulatory20 Aug 2026
Molbio Diagnostics Ltd
Intimation of Closure Trading Window as per SEBI (Prohibition of Insider Trading) Regulations, 2015
Molbio Diagnostics Ltd has announced the closure of its trading window for insiders and designated persons from August 21, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026.
BSENew Listingnew_listing17 Aug 2026
Molbio Diagnostics Ltd
Trading Members of the Exchange are hereby informed that effective from August 17, 2026, the Equity Shares of Molbio Diagnostics Ltd (Scrip Code: 544866) are listed and admitted to dealings ....
Molbio Diagnostics Ltd's equity shares have been listed and admitted to dealings on the BSE, effective August 17, 2026.